Mechanisms of G-CSF-Induced Neuroprotection
G-CSF 诱导的神经保护机制
基本信息
- 批准号:7905765
- 负责人:
- 金额:$ 32.16万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-08-05 至 2013-07-31
- 项目状态:已结题
- 来源:
- 关键词:Academic Medical CentersAdultAffectAnimal ModelApoptosisApoptoticBiochemicalBiochemistryBiologicalBiologyBirthBlood - brain barrier anatomyBrainBrain EdemaBrain Hypoxia-IschemiaBrain InfarctionBrain InjuriesBrain-Derived Neurotrophic FactorCaringCell DeathCerebral hemisphere hemorrhageCessation of lifeClinicalClinical SciencesCytotoxic ChemotherapyDataDisciplineDoctor of PhilosophyDown-RegulationEdemaEncephalopathiesEnvironmentFamilyFoundationsGoalsGranulocyte Colony-Stimulating FactorGranulocyte Colony-Stimulating Factor ReceptorsGrowthGrowth FactorHealthHealthcareHematopoieticHematopoietic SystemHumanHypoxiaHypoxic Brain DamageImmunohistochemistryInfantInterventionIschemic Brain InjuryJanus kinase 2LabelLeadLearningLimb structureLong-Term EffectsMeasuresMediatingMedicalMedical centerMemoryMetabolismMitochondriaModelingMolecularMorphologyMotorNeonatalNeonatal Brain InjuryNeonatal Intensive Care UnitsNervous System PhysiologyNeuraxisNeurodevelopmental DisabilityNeurologicNeuronsNeutropeniaOutcomePathway interactionsPerinatalPhysiologyPreventionProteinsPsychologyRattusReflex actionResearchResearch PersonnelRiskRotarod Performance TestScientistSensorimotor functionsSensory ProcessSignal PathwaySignal TransductionStat3 proteinStem cellsSurvivorsTestingTherapeuticTimeTissuesTransient Cerebral IschemiaTranslational ResearchTraumatic Brain InjuryUnited StatesUnited States National Institutes of HealthUniversitiesUp-RegulationWaterWestern Blottingbrain tissuecerebral atrophyclinical practiceclinically relevantdesigneffective therapyfootimprovedinsightmature animalmembernatural hypothermianeonatal hypoxic-ischemic brain injuryneonateneurobehavioralneuroprotectionneurosurgerypreventprotective effectpublic health relevanceresearch clinical testingsocioeconomicstranslational neurosciencetreatment strategy
项目摘要
DESCRIPTION (provided by applicant): No effective treatment strategies have yet been developed to prevent or reduce neonatal hypoxic/ischemic (HI) brain damage. Granulocyte-colony stimulating factor (G-CSF), a member of growth factor family, mainly stimulates the proliferation and differentiation of neutrophilic progenitor cells in the hematopoietic system. It has been widely used in clinical practice for the treatment of neutropenia associated with cytotoxic therapy. Recent studies have shown that systemic administration of G-CSF in adult animal models has mediated noteworthy neuroprotective effects in traumatic brain injury, focal transient cerebral ischemia, and intracerebral hemorrhage but its mechanism(s) are not fully elucidated. Whether G-CSF has neuroprotective effects following neonatal hypoxia-ischemia is not known. As a medical scientist and new investigator to the NIH, I have focused on this important question because of its health relevance, nationally and locally. Loma Linda University Medical Center has the largest Neonatal Intensive Care Unit (NICU) in the Western United States. I have bridged basic and clinical science disciplines to assemble an outstanding research team for this project. Our preliminary studies reveal a significant reduction in brain atrophy following systemic administration of G- CSF to an established rat model of neonatal HI and offer insight into mechanism of action. They support our central hypothesis that systemic G-CSF treatment protects the brain against HI-induced apoptosis. To test our main hypothesis, this project is designated to elucidate the impact of G-CSF-mediated neuroprotection on neurobehavioral outcomes, and thereby define its therapeutic potential. Equally important, this project is designed to determine the suppression of cell death mechanisms especially the mitochondrial apoptotic pathways that mediates the protective effects of G-CSF. The neuroprotective effects of G-CSF on neuronal death and brain atrophy will be related to neurobehavioral outcomes (Specific Aim 1). Brain damage will be measured by brain tissue loss, edema formation, blood-brain barrier disruption, brain infarction, and cellular morphological changes. To strengthen the clinical relevance of this project, the long-term effect and mechanisms of G-CSF treatment on sensorimotor functions, memory and learning abilities will be evaluated by a battery of neurological tests. Then G-CSF's underlying mechanism will be investigated in greater depth by measuring its effect on HI-induced activation of signaling pathways especially mitochondrial apoptotic pathways (Specific Aim 2). The apoptotic changes will be studied using biochemical and molecular approaches. Achieving our project goal through these specific aims will lay the foundation for clinical evaluation of systemic G-CSF in NICU neonates for prevention and treatment of brain damage from HI. PUBLIC HEALTH RELEVANCE: No effective treatment strategies have yet been developed to prevent or reduce neonatal hypoxic/ischemic brain damage. Our project goal is to relate G-CSF's protection of neonates from hypoxia/ischemia-induced brain damage to both neurological function and underlying mechanism. Achieving our goal will lay the foundation for clinical evaluation of systemic administration of G-CSF in human neonates for prevention and treatment of brain damage from hypoxia/ischemia.
描述(由申请人提供):尚未开发出有效的治疗策略来预防或减少新生儿缺氧/缺血(HI)脑损伤。粒细胞集落刺激因子(G-CSF)是生长因子家族的成员,主要刺激造血系统中的嗜酸性祖细胞增殖和分化。它已广泛用于临床实践中治疗与细胞毒性治疗相关的中性粒细胞减少症。最近的研究表明,在成年动物模型中全身给予G-CSF对创伤性脑损伤、局灶性短暂性脑缺血和脑出血具有显著的神经保护作用,但其机制尚未完全阐明。G-CSF在新生儿缺氧缺血后是否具有神经保护作用尚不清楚。作为一名医学科学家和NIH的新调查员,我一直关注这个重要的问题,因为它与国家和地方的健康相关。洛马琳达大学医学中心拥有美国西部最大的新生儿重症监护病房(NICU)。我在基础和临床科学学科之间架起了桥梁,为这个项目组建了一支优秀的研究团队。我们的初步研究揭示了在对新生儿HI的已建立的大鼠模型全身给予G-CSF后脑萎缩的显著减少,并提供了对作用机制的深入了解。它们支持我们的中心假设,即全身性G-CSF治疗保护脑免受HI诱导的细胞凋亡。为了验证我们的主要假设,本项目旨在阐明G-CSF介导的神经保护对神经行为结果的影响,从而确定其治疗潜力。同样重要的是,该项目旨在确定细胞死亡机制的抑制,特别是介导G-CSF保护作用的线粒体凋亡途径。G-CSF对神经元死亡和脑萎缩的神经保护作用将与神经行为结局相关(具体目标1)。脑损伤将通过脑组织损失、水肿形成、血脑屏障破坏、脑梗塞和细胞形态变化来测量。为了加强该项目的临床相关性,将通过一系列神经学测试评估G-CSF治疗对感觉运动功能、记忆和学习能力的长期影响和机制。然后,通过测量G-CSF对HI诱导的信号通路激活,特别是线粒体凋亡通路的作用,将更深入地研究G-CSF的潜在机制(具体目标2)。将使用生物化学和分子方法研究凋亡变化。通过这些具体的目标实现我们的项目目标,将为NICU新生儿全身性G-CSF预防和治疗HI脑损伤的临床评价奠定基础。公共卫生相关性:尚未开发出有效的治疗策略来预防或减少新生儿缺氧/缺血性脑损伤。我们的项目目标是将G-CSF对新生儿缺氧/缺血诱导的脑损伤的保护与神经功能和潜在机制联系起来。本研究结果为临床评价全身应用G-CSF防治新生儿缺氧缺血性脑损伤奠定了基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jiping Tang其他文献
Jiping Tang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jiping Tang', 18)}}的其他基金
Harnessing blood clot clearance mechanisms after germinal matrix hemorrhage
利用生发基质出血后的血凝块清除机制
- 批准号:
10528489 - 财政年份:2021
- 资助金额:
$ 32.16万 - 项目类别:
Harnessing blood clot clearance mechanisms after germinal matrix hemorrhage
利用生发基质出血后的血凝块清除机制
- 批准号:
10331887 - 财政年份:2021
- 资助金额:
$ 32.16万 - 项目类别:
Harnessing blood clot clearance mechanisms after germinal matrix hemorrhage
利用生发基质出血后的血凝块清除机制
- 批准号:
10203222 - 财政年份:2021
- 资助金额:
$ 32.16万 - 项目类别:
Investigating the role of mast cells in neonatal germinal matrix hemorrhage
研究肥大细胞在新生儿生发基质出血中的作用
- 批准号:
9452501 - 财政年份:2017
- 资助金额:
$ 32.16万 - 项目类别:
Role of NADPH Oxidase in ICH-Induced Brain Injury
NADPH 氧化酶在 ICH 引起的脑损伤中的作用
- 批准号:
6958794 - 财政年份:2005
- 资助金额:
$ 32.16万 - 项目类别:
Role of NADPH Oxidase in ICH-Induced Brain Injury
NADPH 氧化酶在 ICH 引起的脑损伤中的作用
- 批准号:
7140282 - 财政年份:2005
- 资助金额:
$ 32.16万 - 项目类别:
Gleevec Protects Neurovascular Unit by Inhibition of PDGFR
格列卫通过抑制 PDGFR 保护神经血管单位
- 批准号:
8993927 - 财政年份:
- 资助金额:
$ 32.16万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 32.16万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 32.16万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 32.16万 - 项目类别:
Standard Grant
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 32.16万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 32.16万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 32.16万 - 项目类别:
Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
- 批准号:
10065645 - 财政年份:2023
- 资助金额:
$ 32.16万 - 项目类别:
Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 32.16万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 32.16万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 32.16万 - 项目类别:
Grant-in-Aid for Scientific Research (C)